Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab in Aspirin-exacerbated Respiratory Disease (AERD)
NCT03595488Phase 2Completed
- Sponsor
- Rochester General Hospital
- Start
- Sep 2018
- Primary completion
- Dec 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of dupilumab in Aspirin Exacerbated Respiratory Disease (AERD), sponsored by Rochester General Hospital. Started Sep 2018; status: completed.
02
Drugs
03
Conditions
Aspirin Exacerbated Respiratory Disease (AERD)
Beyond the preview
Go deeper on NCT03595488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03595488.